সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 2.75 mg, dipropylenglycolum, excipiens per la preparazione per la 8.4 cm2 con la liberazione di 25 µg/h. - analgesico - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 5.5 mg, dipropylenglycolum, excipiens per la preparazione per 16,8 cm2 con la liberazione di 50 µg/h. - analgesico - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 8.25 mg, dipropylenglycolum, excipiens per la preparazione del 25,2 cm2 con rilascio di 75 µg/h. - analgesico - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 11 mg, dipropylenglycolum, excipiens per la preparazione 33,6 cm2 con la liberazione di 100 µg/h. - analgesico - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - fentanylum - depotpflaster - fentanylum 1.38 mg, dipropylenglycolum, excipiens per la preparazione 4.2 cm2 con la liberazione di 12.5 µg/h. - analgesico - synthetika

ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

takeda pharma a/s - alogliptin benzoato, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico per migliorare il controllo glicemico in pazienti con insulina a una dose stabile e metformina da sola non forniscono un adeguato controllo glicemico.

ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - idrocortisone - insufficienza surrenale - corticosteroidi per uso sistemico - trattamento dell'insufficienza surrenalica negli adulti.

ইতালী - ইতালীয় - AIFA (Agenzia Italiana del Farmaco)

takeda italia s.p.a. - lansoprazolo - lansoprazolo

ইতালী - ইতালীয় - AIFA (Agenzia Italiana del Farmaco)

takeda pharmaceuticals international ag ireland branch - latanio carbonato - latanio carbonato

ইতালী - ইতালীয় - AIFA (Agenzia Italiana del Farmaco)

takeda italia s.p.a. - lansoprazolo - lansoprazolo